Quest Diagnostics Incorporated

DGXNYSEHealthcare● Active

$196.87

$-3.42(-1.71%)

Market Cap$21.8B

P/E Ratio—

52W High$213.5

52W Low$164.65

Avg Volume891K

Open$202.08

Beta0.59

Cash on Hand Financials Revenue

Quest Diagnostics Incorporated (DGX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

DGX · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$420.0M▼ -23.5% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$420.0M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-23.5%

vs prior fiscal year

Latest Quarter

$393.0M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$420.0MCash on Hand

Total Debt$6.92BTotal Debt

Net Cash / Net Debt−$6.50BNet Debt Position

Cash vs Debt Ratio

Cash 6%Quest Diagnostics Incorporated cash as % of market cap: 1.93%% · MCap $22BDebt 94%

Quest Diagnostics Incorporated carries a net debt position of $6.50B. Total debt ($6.92B) exceeds cash on hand ($420.0M). Quest Diagnostics Incorporated cash vs debt ratio: 6% cash / 94% debt.

Net Cash = Cash & ST Investments − Total Debt$420.0M − $6.92B = −$6.50B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

DGX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DGX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$420.0M-23.5%

Dec 31, 2024FY$549.0M-20.0%

Dec 31, 2023FY$686.0M+117.8%

Dec 31, 2022FY$315.0M-63.9%

Dec 31, 2021FY$872.0M-24.7%

DGX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

DGX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Quest Diagnostics IncorporatedYOU

DGX

$420.0M$22B1.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Quest Diagnostics Incorporated (DGX) cash on hand as of December 31, 2025 is $420.0M, comprising $420.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Quest Diagnostics Incorporated cash and short-term investments on the balance sheet (10-K filing). Also referred to as Quest Diagnostics Incorporated cash reserves or cash position.

Quest Diagnostics Incorporated annual cash on hand history shows decreased -23.5% in 2025: decreased -23.5% in 2025. Quest Diagnostics Incorporated cash reserves in 2025 reflect the company's capital allocation strategy.

Quest Diagnostics Incorporated carries total debt of $6.92B against cash of $420.0M, resulting in a net debt position of -$6.50B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

DGX cash on hand · 5 questions

As of December 31, 2025, Quest Diagnostics Incorporated (DGX) has $420,000,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $420,000,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $393,000,000. Data sourced from the annual 10-K filing via FMP.

DGX cash on handDGX cash reservesDGX cash 2025how much cash does DGX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Quest Diagnostics Incorporated · Quest Diagnostics Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025